Clinically, LMP1 expression is correlated with risk stratification, treatment response, and prognosis, and higher LMP1 expression indicates greater SUVmax for NKTCL patients. The gene discussed is PDLIM7; the disease is extranodal nasal NK/T cell lymphoma.